Frontiers in Virology | Antivirals and Vaccines

Guidelines

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Editors

See all

graciela andrei

KU ⁯Leuven

Leuven, Belgium

Specialty Chief Editor

Antivirals and Vaccines
stephan pleschka

Institute of Medical Virology, Faculty of Medicine, University of Giessen

Giessen, Germany

Specialty Chief Editor

Antivirals and Vaccines
arif nur muhammad ansori

Postgraduate School, Universitas Airlangga

Surabaya, Indonesia

Associate Editor

Antivirals and Vaccines
ester ballana

IrsiCaixa

Barcelona, Spain

Associate Editor

Antivirals and Vaccines

Navigation group

Antivirals and Vaccines

Guidelines

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Editors

graciela andrei

stephan pleschka

arif nur muhammad ansori

ester ballana

Articles

''Implementation of recombinant anti-Herpes Zoster vaccination in People Living with HIV: a single-center experience"

Effects of GS-CA1 on nuclear envelope-associated early HIV-1 infection steps

In silico development of a multi-epitope-based vaccine against Burkholderia cepacia complex using reverse vaccinology

Host-directed antiviral therapeutics and the NIAID research agenda: an underexplored frontier

Research Topics

Bridging Gaps in Antiviral Therapy: Innovative Approaches in Drug Discovery and Vaccine Development

Antiviral Immunotherapy: Current Advancement and Translational Potential

Development and Optimization of in vitro Antiviral Drug Screening Assays for Emerging and Re-Emerging Viral Pathogens

Eradicating Polio in Pakistan and Other Countries in the Eastern Mediterranean Region: Epidemiology, Surveillance, and Immunization